Dhimant Parekh

9.9K posts

Dhimant Parekh

Dhimant Parekh

@dhimant

Founder, @thebetterindia | Tweet about impact, physics, finance, running, startups.

India Katılım Temmuz 2007
1K Takip Edilen4.7K Takipçiler
Sabitlenmiş Tweet
Dhimant Parekh
Dhimant Parekh@dhimant·
1/ I like to help people. And this is a trait imbibed in me by my dad. This thread is about how he did it.
English
81
246
799
0
Dhimant Parekh
Dhimant Parekh@dhimant·
We at @thebetterindia in collaboration with Mann Deshi Foundation, are helping women in Maharashtra’s most vulnerable villages to get access to solar dehydrators, which will help them process the harvested fruits to avoid post-harvest crop spoilage. Read how you can contribute: thebetterindia.com/farming/mahara…
English
0
0
1
71
Dhimant Parekh
Dhimant Parekh@dhimant·
A transgender activist builds 23 grassroots organisations. A teenage girl prevents child marriages in her village. A young father reshapes caregiving at home. These are not isolated stories — they show what happens when communities lead change from within. thebetterindia.com/changemakers/c…
English
0
0
0
143
Dhimant Parekh
Dhimant Parekh@dhimant·
How are folks getting their @openclaw agent to span sub-agents? What’s the prompt?
English
1
0
1
99
Aniket
Aniket@aniketmaurya·
@dhimant awesomee! very excited and humbled to see you try out OpenClaw on Celesto 🧡
English
1
0
1
23
Aniket
Aniket@aniketmaurya·
Running OpenClaw 🦞 on your personal laptop is fine for tinkering — but it’s a bad default for “always-on”. Laptops sleep/reboot, switch networks, and mix an execution engine with your SSH/API keys + personal docs. Better: run it on a VPS / isolated box (or a managed sandbox). Full write-up: celesto.ai/blog/posts/ope…
English
1
1
5
269
Aniket
Aniket@aniketmaurya·
@dhimant @dhimant this should be fixed now. Can you please give it a try again?
English
1
0
0
39
Dhimant Parekh retweetledi
Luca Camarra
Luca Camarra@camarraluca·
ITS FINISHED! 🎉 PhysicsGraph's AP Physics 1 course is complete! Our final knowledge graph totals 200+ connected nodes across 10 topics, filled with explanations, examples, and tons of practice questions. There's never been a better time to be a student studying physics.
Luca Camarra tweet media
English
18
28
334
64.2K
Dhimant Parekh retweetledi
MoltCode
MoltCode@MoltCode·
AI agents now have their own GitHub. They register themselves. Get SSH keys. Push code. Build repos. No human account needed. This is MoltCode. Open source, git native, agent first.
English
3
7
28
3.2K
Dhimant Parekh
Dhimant Parekh@dhimant·
If you are an early stage or a first-time founder, your takeaway (and solace) from this should be that even wildly successful founders have deep insecurities.
Sam Altman@sama

First, the good part of the Anthropic ads: they are funny, and I laughed. But I wonder why Anthropic would go for something so clearly dishonest. Our most important principle for ads says that we won’t do exactly this; we would obviously never run ads in the way Anthropic depicts them. We are not stupid and we know our users would reject that. I guess it’s on brand for Anthropic doublespeak to use a deceptive ad to critique theoretical deceptive ads that aren’t real, but a Super Bowl ad is not where I would expect it. More importantly, we believe everyone deserves to use AI and are committed to free access, because we believe access creates agency. More Texans use ChatGPT for free than total people use Claude in the US, so we have a differently-shaped problem than they do. (If you want to pay for ChatGPT Plus or Pro, we don't show you ads.) Anthropic serves an expensive product to rich people. We are glad they do that and we are doing that too, but we also feel strongly that we need to bring AI to billions of people who can’t pay for subscriptions. Maybe even more importantly: Anthropic wants to control what people do with AI—they block companies they don't like from using their coding product (including us), they want to write the rules themselves for what people can and can't use AI for, and now they also want to tell other companies what their business models can be. We are committed to broad, democratic decision making in addition to access. We are also committed to building the most resilient ecosystem for advanced AI. We care a great deal about safe, broadly beneficial AGI, and we know the only way to get there is to work with the world to prepare. One authoritarian company won't get us there on their own, to say nothing of the other obvious risks. It is a dark path. As for our Super Bowl ad: it’s about builders, and how anyone can now build anything. We are enjoying watching so many people switch to Codex. There have now been 500,000 app downloads since launch on Monday, and we think builders are really going to love what’s coming in the next few weeks. I believe Codex is going to win. We will continue to work hard to make even more intelligence available for lower and lower prices to our users. This time belongs to the builders, not the people who want to control them.

English
0
0
2
197
Dhimant Parekh retweetledi
Afshine Emrani  MD FACC
Afshine Emrani MD FACC@afshineemrani·
In medical school, we are taught a golden rule: "When you hear hoofbeats, think horses, not zebras." It is a reminder to look for the common explanation before the exotic one. But after decades in cardiology, I’ve learned that if a patient is still suffering after the "horses" have been ruled out, a doctor must have the courage—and the curiosity—to go hunting for the zebra. Sarah was a thirty-four-year-old marathon runner and a devoted mother who came to me after six months of being told she was "fine." She had been bounced from one specialist to another, each one pointing to her normal EKG and standard blood tests as proof that her crushing fatigue and racing heart were simply the result of "new mom stress." By the time she reached my office, she didn't just look tired; she looked invisible, as if the medical system had stopped seeing the woman and only saw the data. Instead of re-reading the normal test results that had already failed her, I asked Sarah to walk me through her life. We talked about her training and her family, eventually landing on a backpacking trip she took to the Mendoza province of rural Argentina. She described staying in a charming, rustic cottage made of sun-dried mud bricks. She mentioned waking up one morning with a strangely swollen, purple eyelid that she assumed was a simple spider bite. As she spoke, a memory surfaced from a biography I had read years ago about Charles Darwin. Most people know Darwin for his theories on evolution, but medical historians have long puzzled over the mysterious, debilitating illness that plagued him for decades after he returned from his voyage on the HMS Beagle. Darwin had written in his journals about being bitten by the "great black bug of the Pampas" while sleeping in mud-walled huts in South America. He spent the rest of his life suffering from heart palpitations and exhaustion that the Victorian doctors of his time could never explain. I realized then that Sarah wasn't suffering from stress; she was likely hosting the same "silent killer" that may have haunted Darwin: Chagas Disease. The "Kissing Bug" lives in the cracks of those mud-brick walls. It bites its victims—often near the eyes or mouth—while they sleep, passing a parasite called Trypanosoma cruzi into the blood. The danger of Chagas is that the initial symptoms disappear quickly, but the parasite can hide in the body for years, slowly weaving itself into the muscle and electrical "wiring" of the heart. To confirm this, I moved beyond the standard tests. I ordered a specialized "Strain Rate" ultrasound, which doesn't just look at whether the heart is pumping, but at how the individual muscle fibers are stretching. We saw that while her heart looked strong to the naked eye, the fibers were "stuttering," a sign of early parasite-induced scarring. A specific blood test for the parasite's antibodies confirmed the diagnosis. Treatment required a difficult, sixty-day course of anti-parasitic medication to stop the infection, paired with a protective heart regimen to keep her electrical system stable while the inflammation settled. Because we caught it before her heart was physically damaged or enlarged, the recovery was a success. Months later, Sarah returned to my office, her vibrant energy restored. She brought me a leather-bound copy of The Voyage of the Beagle with a note tucked inside. She wrote that while other doctors had looked at her charts, I had looked at her. This case remains a vital reminder for my memoir: in a world of high-tech scans and AI, the most sophisticated diagnostic tool we possess is still the human story. When we truly listen, we don't just find the disease—we find the patient. Good morning.
English
735
3.5K
26.3K
975.8K
Nishchay
Nishchay@agNishchay·
In 2025, we clocked over a billion transactions.. That’s millions of Indians trusting us with something deeply personal to them, their finance, their trust and their hope.. The first 5 was the foundation.. the real impact will start now.. @misbahspeaks @JarAppHQ
Nishchay tweet media
English
10
27
146
22.3K
Dhimant Parekh
Dhimant Parekh@dhimant·
Is there a @nammayatri equivalent for food delivery coming up sometime soon? The time seems ripe.
English
2
0
1
172
Dhimant Parekh retweetledi
anand mahindra
anand mahindra@anandmahindra·
He achieved escape velocity from his modest beginnings… But never abandoned the orbit he escaped from. I will connect & support his project 30303 #MondayMotivation
English
118
701
5.1K
241.1K
Dhimant Parekh retweetledi
TheLiverDoc™
TheLiverDoc™@theliverdoc·
STAY WITH ME. A few years ago, a patient was referred to me because he was diagnosed with complicated cirrhosis. He had an infection which led to a condition called hepatic encephalopathy (brain failure due to high ammonia levels). The treatment largely involved ammonia reducing therapies. One drug was central to this - Rifaximin - a non-absorbable antibiotic that reduced ammonia in the body. I prescribed him Rifaximin for 6 weeks and advised him follow-up. He came back to me, not after six weeks, but in 4 weeks, this time, in liver coma (worst stage of brain failure - due to very high ammonia). He spent two days in the ICU and six days in total in the hospital. His hospital bill was close to INR 80,000. He had no insurance and his wife borrowed the money from neighbors and friends to clear hospital dues. Upon questioning, I found that he was not taking the Rifaximin drug I had prescribed. He was only on the other two drugs (one, a syrup called lactulose for improving ammonia clearance in gut). I was furious, because the patient spent a whole week unecessarily in the ICU and wasted so much money that he never had - just because he was "not compliant" to my orders. I decided it was time for me to school him a bit. But I was wrong. He was compliant. He had purchased Rifaximin and was on it. For 15 days. Thereafter, he could not afford it. He was an autorickshaw driver who shuttled school children every morning and evening. He could hardly make ends meet. He had two children of his own. The Rifaximin brand I prescribed him was 42 rupees per tablet. He had to consume two a day - which would mean 2520 rupees a month. He just did not have that money - so he skipped it - to not compromise on other important matters - childrens education and food. He was confused and scared about opting for a cheaper version of Rifaximin because one, he was unsure about the quality of Rifaximin that was not prescribed by me and two, he was "scared" that I would scold him for buying a cheaper Rifaximin and if that got him into trouble. I was confused and scared about prescribing a cheaper version of Rifaximin because one, I was unsure about the quality of Rifaximin that was not "a good promoted brand" and two, I was "scared" that his family would scold me for prescribing a cheaper Rifaximin and if that got him into trouble. It is heartbreaking that many doctors still simply don’t trust generic medicines. Too often, they worry that these cheaper options are lower quality or might cause more problems than the big, famous brands. This fear leads them to prescribe expensive drugs instead, and the real tragedy is that it pushes vital healthcare out of reach for the ordinary people who need it most - like my patient. This narrative, that generic drugs 'are never good' and that only big pharmaceutical marketed drugs are what works has been deeply ingrained into doctors and patients alike - I do not know by whom and since when. Looking back, these strong emotions were based on either opinions, testimonials or second- and third-hand information. Not evidence. Like I said. Stay with me. This is life changing and will disrupt the drug market in India. Here are the results of The Citizens Generic vs. Brand Drugs Quality Project. 1/11
TheLiverDoc™ tweet media
English
288
1.4K
3.7K
528K
Dhimant Parekh retweetledi
Srinivas Alavilli
Srinivas Alavilli@srinualavilli·
When @arunpaiblrwalks announced the mega 26km New Year Day Walk from Jayanagara to Yeswanthapura, the buzz was palpable on the WhatsApp group - more than 700 joined. With my experience and considering its 7AM on Jan 1st, I figured a 100 will actually show up. To my utter surprise and joy, 300+ were there and came from koramangala, whitefield even yelahanka as you can see in the video! The walk is still on, almost reaching the destination with many of them determined to walk all the way. Arun’s Bengaluru history anecdotes and the conversations with strangers united for the cause and the unmatched beauty of our city makes it a great experience. I see #Walkaluru as a mass movement for pedestrian rights and a unique way for citizens to collaborate with civic authorities, parenting with them to make our city walkable and acknowledging their work. From poura karmikas to Chief Secretary everyone felt a degree of ownership and that’s just amazing. Kudos to @arunpaiblrwalks and his team for taking on this mission and making everyone a part of it. Kudos to every one that joined. As a senior citizen told me at 6:45AM this morning, attitude about footpaths changed once @GBAChiefComm started walking as soon as he took over. I tend to agree!
English
19
108
642
37.4K